Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/5641
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Çolakoglu, Murat | - |
dc.contributor.author | Yenicesu, Müjdat | - |
dc.contributor.author | Akpolat, Tekin | - |
dc.contributor.author | Vural, Abdülgaffar | - |
dc.contributor.author | Utaş, C. | - |
dc.contributor.author | Arinsoy, T. | - |
dc.contributor.author | Sindel, Ş. | - |
dc.date.accessioned | 2019-08-16T11:51:13Z | |
dc.date.available | 2019-08-16T11:51:13Z | |
dc.date.issued | 1998 | - |
dc.identifier.issn | 0028-2766 | - |
dc.identifier.uri | https://hdl.handle.net/11499/5641 | - |
dc.identifier.uri | https://doi.org/10.1159/000045091 | - |
dc.description.abstract | Several patients with end-stage renal disease went to Bombay for renal transplantation from nonrelated living donors and then returned to Turkey for posttransplantation follow-up. The aims of this study are to evaluate the long-term results of renal transplantation from nonrelated living donors in Turkish patients with end-stage renal disease and to discuss the ethical and social aspects of nonrelated kidney donation. One hundred and twenty-seven patients (89 males, 38 females; mean age 38.1, range 17-63 years) were investigated retrospectively. None of the patients went to Bombay on our advice. All transplantations were performed between 1991 and 1995. The mean follow-up period after transplantation was 34.2 (range 1-68) months. Graft survival rates were 85, 83, and 57% after 3 months and 1 and 5 years, respectively. Patient survival rates were 94, 93, and 92% after 3 months and 1 and 5 years, respectively. Seven patients died within the first 3 months after the transplantation. Surgical problems, infections, acute rejection, ciclosporin nephrotoxicity, and hepatic problems were common complications. We conclude that medical and surgical complications occur frequently in paid kidney transplantation, but most of these complications can be prevented by adequate preoperative management, and precautionary measures should be taken to prevent commercialization of renal transplantation before the spread of emotionally related living kidney donation. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Nephron | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Kidney transplantation | en_US |
dc.subject | Non-related living-donor kidneys | en_US |
dc.subject | Organ trading | en_US |
dc.subject | cyclosporin a | en_US |
dc.subject | adolescent | en_US |
dc.subject | adult | en_US |
dc.subject | article | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | graft rejection | en_US |
dc.subject | graft survival | en_US |
dc.subject | human | en_US |
dc.subject | india | en_US |
dc.subject | infection | en_US |
dc.subject | kidney transplantation | en_US |
dc.subject | liver disease | en_US |
dc.subject | living donor | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | medical ethics | en_US |
dc.subject | mortality | en_US |
dc.subject | nephrotoxicity | en_US |
dc.subject | preoperative care | en_US |
dc.subject | priority journal | en_US |
dc.subject | survival rate | en_US |
dc.subject | turkey (republic) | en_US |
dc.subject | Empirical Approach | en_US |
dc.subject | Health Care and Public Health | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Cause of Death | en_US |
dc.subject | Ethics, Medical | en_US |
dc.subject | Female | en_US |
dc.subject | Follow-Up Studies | en_US |
dc.subject | Graft Survival | en_US |
dc.subject | Humans | en_US |
dc.subject | India | en_US |
dc.subject | Kidney Failure, Chronic | en_US |
dc.subject | Kidney Transplantation | en_US |
dc.subject | Living Donors | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Survival Analysis | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Turkey | en_US |
dc.title | Nonrelated living-donor kidney transplantation: Medical and ethical aspects | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 79 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 447 | |
dc.identifier.startpage | 447 | en_US |
dc.identifier.endpage | 451 | en_US |
dc.identifier.doi | 10.1159/000045091 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 9689161 | en_US |
dc.identifier.scopus | 2-s2.0-0031825367 | en_US |
dc.identifier.wos | WOS:000075230300009 | en_US |
dc.owner | Pamukkale_University | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
17
checked on Nov 30, 2024
WEB OF SCIENCETM
Citations
18
checked on Dec 3, 2024
Page view(s)
36
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.